Chick chorioallantoic membrane as an in situ biological membrane for pharmaceutical formulation development: A review

Drug Development and Industrial Pharmacy

Volumn 34, Issue 11, 2008, Pages 1168-1177

  Saw, Constance L L ^a   Heng, Paul W S ^a   Liew, Celine V ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Chick chorioallantoic membrane; Draize test; Drug delivery; Formulation development; Permeation; Transport study

Indexed keywords

ANIMAL TESTING ALTERNATIVE; CHICK; CHORIOALLANTOIS; DRUG FORMULATION; DRUG RESEARCH; DRUG SCREENING; DRUG TRANSPORT; NONHUMAN; PRODUCT DEVELOPMENT; REVIEW;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; EXTRAEMBRYONIC MEMBRANES; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 54349088540     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040801974295     Document Type: Review

References (45)

1. Alany, R. G., Rades, T., Nicoll, J., Tucker, I. G., & Davies, N. M. (2006). W/O microemulsions for ocular delivery: Evaluation of ocular irritation and precorneal retention. J. Control Release, 111, 145-152.
2. Anderson, D., & Russell, T. (1995). The status of alternative methods in toxicology. Cambridge, UK: The Royal Society of Chemistry.
3. Ausprunk, D. H., Knighton, D. R., & Folkman, J. (1974). Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study. Dev. Biol, 38, 237-248.
4. Beveridge, W. I. B., & Burnet, F. M. (1946). The cultivation of viruses and rickettsiae in the chick embryo: His Majesty's Stationery Office. (Medical Research Council, Special Rep. Series No. 256). London
5. Brantner, A. H., Quehenberger, F., Chakraborty, A., Polligger, J., Sosa, S., & Della Loggia, R. (2002). HET-CAM bioassay as in vitro alternative to the croton oil test for investigating steroidal and non-steroidal compounds. Altex, 19, 51-56.
6. Chin, W. W., Lau, W. K., Bhuvaneswari, R., Heng, P. W., & Olivo, M. (2007). Chlorin e6-polyvinylpyrrolidone as a fluorescent marker for fluorescence diagnosis of human bladder cancer implanted on the chick chorioallantoic membrane model. Cancer Lett., 245, 127-133.
7. Clothier, R. H., Atkinson, K. A., Garle, M. J., Ward, R. K., & Willshaw, A. (1995). The development and evaluation of in vitro tests by the frame alternatives laboratory. Altern. Lab Anim., 23, 75-90.
8. Draize, J. H. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol Exp. Ther., 82, 377-390.
9. Hammer-Wilson, M. J., Akian, L., Espinoza, J., Kimel, S., & Berns, M. W. (1999). Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for topically applied photosensitizers. J. Photochem. Photobiol. B, 53, 44-52.
10. Hammer-Wilson, M. J., Cao, D., Kimel, S., & Berns, M. W. (2002). Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for photosensitizers administered intraperitoneally (IP) into the chick embryo. Photochem. Photobiol. Sci., 1, 721-728.
11. Hidalgo, J. J. (2001). Assessing the absorption of new pharmaceuticals. Curr. Top. Med. Chem., 1, 385-401.
12. Kolar, R. (2006). Animal experimentation. Sci. Eng. Ethics, 12, 111-122.
13. Kunzi-Rapp, K., Genze, F., Kufer, R., Reich, E., Hautmann, R. E., & Gschwend, J. E. (2001). Chorioallantoic membrane assay: vascularized 3-dimensional cell culture system for human prostate cancer cells as an animal substitute model. J. Urol., 166, 1502-1507.
14. Kunzi-Rapp, K., Ruck, A., & Kaufmann, R. (1999). Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch. Dermatol. Res., 291, 290-295.
15. Lallemand, F., Furrer, P., Felt-Baeyens, O., Gex-Fabry, M., Dumont, J. M., Besseghir, K., & Gurny, R. (2005). A novel water-soluble cyclosporine A prodrug: Ocular tolerance and in vivo kinetics. Int. J. Pharm., 295, 7-14.
16. Lange, N., Ballini, J. P., Wagnieres, G., & van den Bergh, H. (2001). A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV. Invest. Ophthalmol. Vis. Sci., 42, 38-46.
17. Lawrence, R. S., Groom, M. H., Ackroyd, D. M., & Parish, W. E. (1986). The chorioallantoic membrane in irritation testing. Food Chem. Toxicol., 24, 497-502.
18. Leighton, J., Nassauer, J., Tchao, R., Gottfried, V., Lindenbaum, E. S., & Kimel, S. (1985). The chick embryo in toxicology: An alternative to the rabbit eye. Food Chem. Toxicol., 23, 293-298.
19. Luepke, N. P. (1985). Hen's egg chorioallantoic membrane test for irritation potential. Food Chem. Toxicol., 23, 287-291.
20. Leng, T., Miller, J. M., Bilbao, K. V., Palanker, D. V., Huie, P., & Blumenkranz, M. S. (2004). The chick chorioallantoic membrane as a model tissue for surgical retinal research and simulation. Retina, 24, 427-434.
21. Maragoudakis, M. E., Panoutsacopoulou, M., & Sarmonika, M. (1988). Rate of basement membrane biosynthesis as an index to angiogenesis. Tissue Cell, 20, 531-539.
22. Martins, T., Pauluhn, J., & Machemer, L. (1992). Analysis of alternative methods for determining ocular irritation. Food Chem Toxicol., 30, 1061-1067.
23. McCormick, J. F., Nassauer, J., Bielunas, J., & Leighton, J. (1984). Anatomy of the chick chorioallantoic membrane relevant to its use as a substrate in bioassay systems. Scan Electron Microsc., 2023-2030.
24. Mysliveckova, A., & Rychter, Z. (1975). Electron microscopy analysis of differentiation of the wall and capillary bed of the chick embryo allantochorion. Folia Morphol. (Praha), 23, 306-319.
25. Neumann, N. J., Holzle, E., Lehmann, P., Rosenbruch, M., Klaucic, A., & Plewig, G. (1997). Photo hen's egg test: a model for phototoxicity. Br. J. Dermatol., 136, 326-330.
26. Pawar, P. K., & Majumdar, D. K. (2006). Effect of formulation factors on in vitro permeation of moxifloxacin from aqueous drops through excised goat, sheep, and buffalo corneas. AAPS PharmSciTech., 7, Article 13, DOI: 10.1208/pt070113.
27. Pegaz, B., Debefve, E., Ballini, J. P., Wagnieres, G., Spaniol, S., Albrecht, V., Scheglmann, D. V., Nifantiev, N. E., van den Bergh, H., & Konan-Kouakou, Y. N. (2006). Photothrombic activity of m-THPC-loaded liposomal formulations: Pre-clinical assessment on chick chorioallantoic membrane model. Eur. J. Pharm. Sci., 28, 134-140.
28. Ribatti, D., Conconi, M. T., Nico, B., Baiguera, S., Corsi, P., Parnigotto, P. P., & Nussdorfer, G. G. (2003). Angiogenic response induced by acellular brain scaffolds grafted onto the chick embryo chorioallantoic membrane. Brain Res., 989, 9-15.
29. Ribatti, D., Nico, B., Morbidelli, L., Donnini, S., Ziche, M., Vacca, A., Roncali, L., & Presta, M. (2001). Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J. Vasc. Res., 38, 389-397.
30. Ribatti, D., Nico, B., Vacca, A., Roncali, L., Burri, P. H., & Djonov, V. (2001). Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Rec., 264, 317-324.
31. Ribatti, D., Nico, B., Vacca, A., Roncali, L., & Presta, M. (1999). Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane. Angiogenesis, 3, 89-95.
32. Richardson, M., & Singh, G. (2003). Observations on the use of the avian chorioallantoic membrane (CAM) model in investigations into angiogenesis. Curr. Drug Targets Cardiovasc. Haematol. Disord., 3, 155-185.
33. Romanoff, A. L., & Romanoff, A. J. (1967). Biochemistry of the avian embryo: A quantitative analysis of prenatal development. New York: Interscience Publisher.
34. Rous, P., & Murphy, J. B. (1911). Tumor implantations in the developing embryo. JAMA, 56, 741-742.
35. Ruck, A., Akgun, K., Heckelsmiller, K., Beck, G., Genze, F., & Steiner, R. (1998). Confocal observation of hydrophilic and lipophilic photosensitizers in endothelial cells, lumen of the vessels, interstitium and tumor cells using the chicken chorioallantoic membrane. SPIE, 3247, 63-68.
36. Russell, W. M. S., & Burch, R. L. (1959). The principles of humane experimental technique. Springfield, IL: Charles C. Thomas, Co.
37. Saw, C. L., Heng, P. W., Chin, W. W., Soo, K. C., & Olivo, M. (2006). Enhanced photodynamic activity of hypericin by penetration enhancer N-methyl pyrrolidone formulations in the chick chorioallantoic membrane model. Cancer Lett., 238, 104-110.
38. Saw, C. L., Olivo, M., Chin, W. W., Soo, K. C., & Heng, P. W. (2005). Transport of hypericin across chick chorioallantoic membrane and photodynamic therapy vasculature assessment. Biol. Pharm. Bull., 28, 1054-1060.
39. Saw, C. L., Olivo, M., Chin, W. W., Soo, K. C., & Heng, P. W. (2007). Superiority of N-methyl pyrrolidone over albumin with hypericin for fluorescence diagnosis of human bladder cancer cells implanted in the chick chorioallantoic membrane model. J. Photochem. Photobiol. B, 86, 207-218.
40. Vargas, A., Eid, M., Fanchaouy, M., Gurny, R., & Delie, F. (2008) In vivo photodynamic activity of photosensitizer-loaded nanoparticles: Formulation properties, administration parameters and biological issues involved in PDT outcome. Eur. J. Pharm. Biopharm., 69, 43-53.
41. Vargas, A., Pegaz, B., Debefve, E., Konan-Kouakou, Y., Lange, N., Ballini, J. P., van den Bergh, H., Gurny, R., & Delie, F. (2004). Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos. Int. J. Pharm., 286, 131-145.
42. Wigglesworth, C. (2006). Grants proposals and animal use protocols: is the IACUC playing by the rules? A word from OLAW. Lab Anim. (NY), 35, 18.
43. Winternitz, C. I., Jackson, J. K., Oktaba, A. M., & Burt, H. M. (1996). Development of a polymeric surgical paste formulation for taxol. Pharm. Res., 13, 368-375.
44. Wutzler, P., Sauerbrei, A., Härtl, A., & Reimer, K. (2003). Comparative testing of liposomal and aqueous formulations of povidone-iodine for their angioirritative potential at the chorioallantoic membrane of ex ovo cultivated chick embryos. Dermatology, 207, 43-47.
45. Zwilling, E. (1959). A modified chorioallantoic grafting procedure. Transplant. Bull., 6, 115-116.